Rznomics

Developer of drugs for anti-cancer and refractory diseases based on RNA Platform technology

placeYongin Si, Gyeonggi Do, South Korea calendar_todayFounded 2017 groups39 employees language rznomics.com

Registered entities

Innovation

20 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady.

Social engagement

Social engagement: 1.3K social following, 10 posts in the last 12 months — above the industry median.

Recent activity

23 Jun 2026
Event
BIO International Convention 2026
15 Jun 2026
Event
ASNO 2026 Annual Meeting
27 May 2026
Milestone
regulatory
Coming soon